Predictive Oncology Inc. — Director's Dealing 2016

Sep 19, 2016

SEC Form 4/A — Form 4/A

Issuer: Skyline Medical Inc. (SKLN)
CIK: 0001446159
Period of Report: 2016-09-16

Reporting Person: JOHNSON DAVID O. (Chief Operating Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-09-16	Stock Options (right to buy)	$0.1679	A	89339	Acquired	2026-09-16	Common Stock (89399)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	17302	Direct

Footnotes

F1: 191 shares held jointly with spouse.

F2: This amendment is being filed to correct the original form to reflect that this option is an acquisition.